202 related articles for article (PubMed ID: 229763)
1. Assessment of cellular immune response to cancer of the breast.
Herberman RB
Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
[TBL] [Abstract][Full Text] [Related]
2. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
Rudczynski AB; Dyer CA; Mortensen RF
Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
[No Abstract] [Full Text] [Related]
3. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
Black MM; Zachrau RE; Shore B; Dion AS; Leis HP
Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
[No Abstract] [Full Text] [Related]
4. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
[TBL] [Abstract][Full Text] [Related]
6. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
Black MM; Zachrau RE
J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
[TBL] [Abstract][Full Text] [Related]
7. Specificity of the simultaneous cell-mediated immune reactivity to RIII murine mammary tumor virus glycoprotein 55 and human breast cancer tissues.
Zachrau RE; Black MM; Dion AS; Shore B; Williams CJ; Leis HP
Cancer Res; 1978 Oct; 38(10):3414-20. PubMed ID: 80264
[No Abstract] [Full Text] [Related]
8. Leukocyte migration inhibition response to breast cancer antigens and to mouse mammary tumor virus in women with primary breast cancer.
Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
Surg Forum; 1978; 29():167-9. PubMed ID: 233830
[No Abstract] [Full Text] [Related]
9. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ
Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease.
Cannon GB; Barsky SH; Alford TC; Jerome LF; Tinley V; McCoy JL; Dean JH
J Natl Cancer Inst; 1982 Jun; 68(6):935-43. PubMed ID: 6283226
[TBL] [Abstract][Full Text] [Related]
11. Immunopathology of breast cancer.
Black MM
Pathobiol Annu; 1977; 7():213-30. PubMed ID: 201905
[No Abstract] [Full Text] [Related]
12. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
Cervantes C; Muzio E; Exposito G; Garcia ME
Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
[No Abstract] [Full Text] [Related]
14. Effect of murine milk samples and human breast tissues on human leukocyte migration indices.
Black MM; Moore DH; Shore B; Zachrau RE; Leis H
Cancer Res; 1974 May; 34(5):1054-60. PubMed ID: 4363063
[No Abstract] [Full Text] [Related]
15. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immune responses of breast cancer patients to autologous tumor-associated antigens.
Dean JH; McCoy JL; Cannon GB; Leonard CM; Perlin E; Kreutner A; Oldham RK; Herberman RB
J Natl Cancer Inst; 1977 Mar; 58(3):549-55. PubMed ID: 138751
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
Grosser N; Thomson DM
Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
[TBL] [Abstract][Full Text] [Related]
18. Lymphoproliferative responses to mouse mammary tumor virus in lymphocyte subsets of breast cancer patients.
Lopez DM; Parks WP; Silverman MA; Distasio JA
J Natl Cancer Inst; 1981 Aug; 67(2):353-8. PubMed ID: 6267344
[TBL] [Abstract][Full Text] [Related]
19. Peripheral leukocyte migration inhibition reactivity to breast cancer antigens in patients with breast cancer and in normal controls.
Brandes LJ; Goldenberg GJ
Cancer Res; 1976 Oct; 36(10):3707-10. PubMed ID: 953996
[TBL] [Abstract][Full Text] [Related]
20. [Cellular antitumor immunity in an autologous system in stomach cancer].
Kurtenkov OA
Vopr Onkol; 1981; 27(6):36-40. PubMed ID: 7269415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
